Valuable monitoring of tumor development – with Magnetic Resonance

Monitoring the development of tumors and lesions is very important during breast cancer therapy. A solution is required that provides full coverage of the breast and needed information - both anatomical and metabolic tissue information.

Our software solution syngo VIEWS can help provide ongoing anatomical and functional information about the lesion throughout the therapy process.
syngo VIEWS

Siemens' unique Tim (Total imaging matrix) technology delivers accelerated acquisition speed – while still providing the high spatial resolution.
Tim Technology

In addition, syngo GRACE, our solution for quantitative MR breast spectroscopy, can provide quantified metabolic tissue information by utilizing Choline as a biomarker. syngo GRACE provides essential information about the biochemical composition of breast lesions, and helps increase confidence in the assessment of therapy efficacy.
syngo GRACE

“syngo GRACE shows great promise as a way to differentiate between benign and malignant lesions, and to gauge the effect of chemotherapeutic agents in patients with locally advanced breast cancer.”

Dr. Mitsuhiro Tozaki, Director of Breast Center, Kameda Medical Center, Chiba, Japan